MD Stock Analysis: Buy, Sell, or Hold?
MD - Pediatrix Medical Group, Inc.
$22.49
-0.99 (-4.22%)
▼
5d:
-4.34%
30d:
+1.26%
90d:
+4.51%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When MD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MD shows positive signals but monitor for confirmation. Market pricing in 0.0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: MD shows positive signals but monitor for confirmation. Market pricing in 0.0% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$27.08
Based on 3.9% avg growth
INTRINSIC VALUE TODAY
$16.81
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MD is currently trading at $22.49, which is considered fair relative to its 30-day fair value range of $21.95 to $23.40. The stock's valuation (Forward PE: 9.5) is in line with its historical norms (9.5). At these levels, the market is pricing in -0.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MD is in a uptrend. Immediate support is located at $19.65, while resistance sits at $24.36. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: MD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MD is in a uptrend. Immediate support is located at $19.65, while resistance sits at $24.36. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: MD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$21.95 -
$23.40
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.2%)
- NEUTRAL: Near Wall St target ($23.17)
- NEUTRAL: Market pricing in -0.0% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$21.95 -
$23.40
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$19.65
Resistance Level
$24.36
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.53
Wall Street Target
$23.17
(+3.0%)
Revenue Growth (YoY)
3.9%
Earnings Growth (YoY)
50.0%
Profit Margin
9.0%
PE vs Historical
9.5 vs 9.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
0%
(market-implied from PE analysis)
1-Year Target
$22.49
(0%)
2-Year Target
$22.49
(0%)
3-Year Target
$22.49
(0%)
3-Yr Target (if PE normalizes)
(PE: 10→10)
PE COMPRESSION
$22.42
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 3.7%)
$58.01
(+158%)
Base:
(SPY PE: 9.5, Growth: 3.7%)
$25.05
(+11%)
Bear:
(PE: 8.1, Growth: 3.7%)
$21.29
(-5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 11.40 | Current EPS (TTM): $2.06
Bull Case
$29.58
(+32%)
Analyst growth 14.5%, PE expands to 12.5
Base Case
$26.89
(+20%)
Market implied 14.5%, PE stable at 11.4
Bear Case
$15.97
(-29%)
Severe decline -20.0%, PE contracts to 9.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 18, 2026 8:19 AM ET
Data refreshes hourly during market hours. Next update: 9:19 AM
Data refreshes hourly during market hours. Next update: 9:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark S Ordan
SELL
23000 shares
2025-12-15
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 64 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 61 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$23 | 59 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 59 HOLD |
